Overall infections, including among asymptomatic patients, were reduced by 75 per cent.
“This ground-breaking research supports the British government’s decision to begin inoculating its citizens with a single dose of the vaccine,” Prof. Arnon Afek, Deputy Director General of Sheba Medical Centre said.
Professor Eyal Leshem, Director of Sheba Medical Centre’s Institute for Travel & Tropical Medicine added, “This is the first study assessing effectiveness of a single vaccine dose in real life conditions and shows early effectiveness, even before the second dose was administered.”
